stockrowZoetis Inc.
ZTS Healthcare Drug Manufacturers Specialty & Generic
Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.
- Revenue
- −0.24%
- EPS
- +2.48%
- Free cash flow
- +17.4%
- Total debt
- +37.5%
Quarter to June 2026, against a year earlier
Follow ZTS
Alert me
Zoetis Inc. (ZTS) Gross margin
Zoetis Inc.'s gross margin over the twelve months to 30 June 2026 was 71.7%, down 0.2 percentage points from fiscal 2025 (71.8%). Over the past ten years it has ranged from 63.5% (fiscal 2015) to 71.8% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 71.8% | 1.22 |
| FY2024 | 70.6% | 0.59 |
| FY2023 | 70.0% | 0.40 |
| FY2022 | 69.6% | (0.75) |
| FY2021 | 70.4% | 1.20 |
| FY2020 | 69.2% | 1.00 |
| FY2019 | 68.2% | 0.99 |
| FY2018 | 67.2% | 0.64 |
| FY2017 | 66.6% | 0.63 |
| FY2016 | 65.9% | 2.39 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 72.7% | 1.07 |
| Mar 2026 | 71.7% | 0.93 |
| Dec 2025 | 70.7% | (0.81) |
| Sep 2025 | 71.5% | (1.62) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| UTHR United Therapeutics Corporation compare | 86.3% |
| ZTS Zoetis Inc. | 71.7% |
| TAK Takeda Pharmaceutical Co. compare | 65.9% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 53.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on ZTS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement